Topics

Articles

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

Access USA 2024: The State of the Industry

With out-of-pocket healthcare costs resulting in financial issues for patients, a cross-sectional study closely examines whether they are linked to more premature deaths.  

Is There a Correlation Between Medical Debt and Health Status?

Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag. 

Revolutionizing Rare Disease Treatment: Embracing the Patient-Centric Transformation in Pharmaceutical Customer Engagement

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics. 

Examining the Impact of the COVID-19 Pandemic on Patient Portal Use

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now. 

Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act

A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective. 

Finding the Ideal Set of Oncology Employer Benefits 

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act. 

Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act

An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence. 

Does Food Insecurity Impact Adherence to Antihypertensive Medications?

The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.

Fortrea Grows Its Non-Commercial Specialty Pharma Offering

Cabenuva (cabotegravir + rilpivirine) showed superior efficacy in maintaining viral load suppression in patients with HIV compared with standard of care daily oral antiretroviral treatment.

Patient Support